Kokuina E, Tamargo BTO, Prado BA, Matos FY, Paéz SD, Hernández MH

Language: Spanish
References: 27
Page: 1-12
PDF size: 479.57 Kb.

ABSTRACT

Introduction: Celiac disease is an immune-mediated enteropathy that has been increasingly recognized as a common disease, affecting both the pediatric and adult population. Serology is a key component of the detection and diagnosis of celiac disease.
Objective: To evaluate the diagnostic usefulness of anti-tissue transglutaminase antibodies in individuals with chronic gastrointestinal symptoms.
Methods: In a cutoff study, anti-tissue transglutaminase IgA/G antibodies were determined in 87 adult and pediatric patients with medical indication for celiac disease antibodies. Anti-tissue transglutaminase IgA/G was performed by enzyme-linked immunoadsorbent assay and multiplex immunoblot assay. Mann-Whitney U test was applied and kappa correspondence coefficient was calculated.
Results: The seroprevalence of anti-tissue transglutaminase IgG/IgA was 8.05 % (7/87) by enzyme-linked immunosorbent assay. The qualitative results of the enzyme-linked immunosorbent assay and immunoblot for anti-tissue transglutaminase were consistent with a kappa coefficient of 0.407 (p=0.004). The distribution of the concentration of anti-TGt IgA/G antibodies obtained by enzyme-linked immunosorbent assay with respect to negative and positive immunoblot results was not significant (p=0.08). Patients with presence of anti-tissue transglutaminase IgA/G by enzyme-linked immunosorbent assay obtained the definitive diagnosis of celiac disease confirmed by duodenal biopsy.
Conclusions: The usefulness of detection of anti-tissue transglutaminase IgA/G antibodies by enzyme-linked immunosorbent assay as a first diagnostic step of celiac disease in patients with gastrointestinal symptoms was confirmed.

REFERENCES

1. Lebwohl B, Sanders DS, Green PHR. Coeliac disease. Lancet. 2018;391:70-81. DOI: http://dx.doi.org/10.1016/S0140-6736(17)31796-8)1.

2. Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, et al. Global prevalence of celiac disease: systematic review and meta- analysis. Clin Gastroenterol Hepatol. 2018;16:823-36. DOI: https://10.1016/j.cgh.2017.06.0372.

3. Lebwohl B, Rubio-Tapia A. Epidemiology, presentation, and diagnosis of celiac disease. Gastroenterology 2021;160:63-75. DOI: https://10.1053/j.gastro.2020.06.0983.

4. Raiteri A, Granito A, Giamperoli A, Catenaro T, Negrini G, Tovoli F. Current guidelines for the management of celiac disease: A systematic review with comparative analysis. World J Gastroenterol. 2022;28:154-75. DOI: https://dx.doi.org/10.3748/wjg.v28.i1.1544.

5. Husby S, Murray JA, Katzka DA. AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease: Changing Utility of Serology and Histologic Measures: Expert Review Gastroenterology. 2019;156:885-9. DOI: https://10.1053/j.gastro.2018.12.0105.

6. Hopper AD, Hadjivassiliou M, Hurlstone DP, Lobo Aj, McAlindon ME, Egner W, et al. What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis. Clin Gastroenterol Hepatol. 2008;6:314-20. DOI: https://10.1016/j.cgh.2007.12.0086.

7. Oberhüber G, Granditsch G, Vogelsang H. The histopathology of celiac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11:1185-94. DOI: https://10.1097/00042737-199910000-000197.

8. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-74. PMID: 843571

9. Collin P, Vilppula A, Luostarinen L, Holmes GKT, Kaukinen K. Review article: coeliac disease in later life must not be missed. Aliment Pharmacol Ther. 2018;7:563-72. DOI: https://10.1111/apt.144909.

10. Catassi C, Kryszak D, Bhatti B, Sturgeon C, Helzlsouer K, Clipp SL, et al. Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Ann Med 2010;42:530-38. DOI: https://10.3109/07853890.2010.51428510.

11. Andrén Aronsson C, Lee HS, Hard Af Segerstad EM, Uusitalo U, Yang J, Koletzko S, et al. Association of gluten intake during the first 5 years of life with incidence of celiac disease autoimmunity and celiac disease among children at increased risk. JAMA 2019;322:514-23. DOI: https://10.1001/jama.2019.1032911.

12. King JA, Jeong J, Underwood FE, Quan J, Panaccione N, Windsor JW, et al. Incidence of Celiac Disease Is Increasing Over Time: A Systematic Review and Meta-analysis. Am J Gastroenterol 2020;115:507-25. DOI: https://10.14309/ajg.000000000000052312.

13. Jansson-Knodell CL, Hujoel IA, West CP, Taneja V, Prokop LJ, Rubio-Tapia A, et al. Sex Difference in Celiac Disease in Undiagnosed Populations: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2019;17:1954-968.e13 DOI: https://10.1016/j.cgh.2018.11.01313.

14. Katz KD, Rashtak S, Lahr BD, Melton LJ, Krause PK, Maggi K, et al. Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol. 2011;106:1333-9. DOI: https://10.1038/ajg.2011.2114.

15. Caio G, Volta H, Sapone A, Leffler DA, De Giorgio R, Catassi C, et al. Celiac disease: a comprehensive current Review. BMC Medicine. 2019;17:142. DOI: https://doi.org/10.1186/s12916-019-1380-z15.

16. Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA. For the American College of Gastroenterology. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108:656-77. DOI: https://10.1038/ajg.2013.7916.

17. García Menéndez G, Andrade Ruiseco M, Valbuena Rodríguez M, Alfonso González B, Hernández Acea B, Kokuina E, et al. Insuficiencias metodológicas lastran el diagnóstico de la enfermedad celiaca. Rev cuban pediatr, 2019;91:898. ISSN digital: 1561-3119. Disponible en: http://scielo.sld.cu17.

18. Husby S, Koletzko S, Korponay-Szabo IR, Mearin ML, Phillips A, Shamir R, et al. For the ESPGHAN Working Group on Coeliac Disease Diagnosis; ESPGHAN Gastroenterology Committee, European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. European Society For Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54:136-60. DOI: https://10.1097/MPG.0b013e31821a23d018.

19. Werkstetter KJ, Korponay-Szabo IR, Popp A, Villanacci V, Salemme M, Heilig G, et al. Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice. Gastroenterol. 2017;153:924-35. DOI: https://10.1053/j.gastro.2017.06.00219. .

20. Sugai E, Hwang HJ, Vazquez H, Moreno ML, Costa F, Longarini G, et al. Should ESPGHAN guidelines for serologic diagnosis of celiac disease be used in adults? A prospective analysis in an adult patient cohort with high pretest probability. Am J Gastroenterol. 2015;110:150405. DOI: https://10.1038/ajg.2015.24220.

21. Losurdo G, Di Leo M, Santamato E, Arena M, Rendina M, Luigiano C, et al. Serologic diagnosis of celiac disease: May it be suitable for adults? World J Gastroenterol. 2021;27:7233-39. DOI: https://dx.doi.org/10.3748/wjg.v27.i42.723321.

22. Efthymakis K, Serio M, Milano A, Laterza F, Bonitatibus A, Di Nicola M, et al. Application of the Biopsy-Sparing ESPGHAN Guidelines for Celiac Disease Diagnosis in Adults: A Real-Life Study. Dig Dis Sci. 2017;62:2433-9. DOI: https://10.1007/s10620-017-4672-122.

23. Blanco-Rabasa E, Sagaró E, Fragoso T, Castañeda C, Valenti J. Enfermedad celíaca. Estudio de 36 casos. Rev cuban Pediatr. 1975;47:209-29. ISSN digital: 1561-3119.

24. Castañeda C. Enfermedad celíaca en Cuba y sus cuarenta años de experiencias y realidades para su diagnóstico. Rev cuban pediatr. 2016;88:483-97. ISSN digital: 1561-3119.

25. Sorell L, Garrote JA, Acevedo B, Arranz E. One-step immune- chromatographic assay for screening of coeliac disease. Lancet. 2002;359:945-6. DOI: https://10.1016/S0140-6736(02)08046-725.

26. Guerreiro Hernández AM, Villaescusa Blanco R, Morera Barrios LM, Alonso Valle M, Martínez Cardet L, Junco González Y. Detección de anticuerpos antigliadina y antitransglutaminasa en pacientes con clínica sugestiva de enfermedad celíaca. Rev. Cuban. hematol inmunol hemoter. 2010;26:28-32. ISSN digital: 1561-2961

27. Creed F, Ratcliffe J, Fernandez L, Tomenson B, Palmer S, Rigby C, et al. Health related quality of life and health care costs in severe, refractory irritable bowel syndrome. Ann Intern Med. 2001;134:860-8. DOI: https://10.7326/0003-4819-134-9_part_2-200105011-0001027.